换一批ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression.
第一作者：
Taku,Kato
第一单位：
Department of Urology, Gifu University Graduate School of Medicine, Japan.
作者：
医学主题词
抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);细胞系, 肿瘤(Cell Line, Tumor);抗药性, 肿瘤(Drug Resistance, Neoplasm);基因表达调控, 酶学(Gene Expression Regulation, Enzymologic);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);男(雄)性(Male);基质金属蛋白酶9(Matrix Metalloproteinase 9);肿瘤侵润(Neoplasm Invasiveness);紫杉酚(Paclitaxel);前列腺肿瘤(Prostatic Neoplasms);原癌基因蛋白质c-ets-1(Proto-Oncogene Protein c-ets-1);增量调节(Up-Regulation)
DOI
10.1016/j.bbrc.2011.12.047
PMID
22206665
发布时间
2018-12-01
- 浏览43
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
